Form 4: ResMed Director Peter Farrell Sells 2,000 Shares Under 10b5-1 Plan
SEC Form 4 Filing
Peter Farrell, a director at ResMed Inc., sold 2,000 shares of common stock at a price of $227.71 per share on March 5, 2025, under a pre-arranged 10b5-1 trading plan.
Summary
- On March 5, 2025, Peter C. Farrell, a director of ResMed Inc. (RMD), sold 2,000 shares of ResMed common stock.
- The sale was executed at a price of $227.71 per share.
- The transaction was conducted under a Rule 10b5-1 plan adopted on May 28, 2024.
- Following the transaction, Farrell directly owns 75,218 shares of ResMed common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction was conducted under a pre-arranged 10b5-1 trading plan, which is a common practice and doesn't necessarily reflect the director's current outlook on the company.
Industry Context
Sales by company directors are a normal part of corporate governance. Investors often look at the reasons behind insider sales to gauge sentiment. Sales under 10b5-1 plans are less indicative of current sentiment as they are pre-arranged.
Key Dates
| Date | Description |
|---|---|
| 2024-05-28 | Date of adoption of the Rule 10b5-1 plan |
| 2025-03-05 | Date of the stock sale transaction |
| 2025-03-06 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.